The Food and Drugs Authority (FDA) says it would soon clamp down on non-iodised salt products on the markets to curb the occurrence of iodine deficiency disorders.
Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, ...
Over 35 years after the first study linking Red 3 to thyroid cancer in rats was published, the US is beginning to wean it out ...
The thyroid is located below the larynx and any disorders involving abnormalities of this gland can have a widespread impact ...
The US Food and Drug Administration announced this month that it's effectively banning Red No. 3, the controversial ...
However, mounting scientific evidence suggests that consuming Red 3 poses significant health risks. These risks prompted ...
New Delhi: In line with the 'Not of Standard Quality' data provided by states, the apex drug regulatory body, the Central ...
However, mounting scientific evidence suggests that consuming Red 3 poses significant health risks. These risks prompted ...
However, mounting scientific evidence suggests that consuming Red 3 poses significant health risks. These risks prompted California to ban its use in food in 2023 and the Food and Drug Administration ...
Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (OTC Pink:VYYRF) ("Voyageur" or the "Company"), a company planning to vertically integrate the medical imaging industry, is pleased to announce that it has ...
Drug discovery is the process through which potential new medicines are identified. It involves a wide range of scientific disciplines, including biology, chemistry and pharmacology. Large-scale ...
The National Pharmaceuticals Pricing Authority (NPPA) has sought certain data from concerned drug manufacturers and marketing companies for fixation of ceiling prices for ...